Health
Mefloquine shows potential as anti-SARS-CoV-2 drug – News-Medical.Net
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome…
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral loadin vitro. The study is currently available on the bioRxiv* preprint server.
The recent pandemic of coronavirus disease 2019 (COVID-19) has put a substantial amount of burden on healthcare…
-
Noosa News22 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News23 hours agoYoung voices shape Sunshine Coast’s future
-
Business23 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News20 hours agoStar Entertainment signs $300m lifeline deal with US gaming giant Bally’s